Liu Y, Xu Z, Zhou J, Chen A, Zhang J, Kang X
Chin Med J (Engl). 2024; 137(14):1736-1743.
PMID: 38710539
PMC: 11268825.
DOI: 10.1097/CM9.0000000000003024.
Liu S, He M, Jiang J, Duan X, Chai B, Zhang J
Cell Commun Signal. 2024; 22(1):108.
PMID: 38347543
PMC: 10860266.
DOI: 10.1186/s12964-023-01381-0.
Mihu C, Popescu C, Neag M, Bocsan I, Melincovici C, Baican A
J Clin Med. 2023; 12(18).
PMID: 37762940
PMC: 10531900.
DOI: 10.3390/jcm12186000.
Shokri F, Rezapoor S, Najafi M, Asadi M, Alavije M, Abolhassani M
Vacunas. 2022; 24(2):141-149.
PMID: 36211984
PMC: 9531663.
DOI: 10.1016/j.vacun.2022.09.077.
Lane J, Stahly S, Sills A, Wagner S, Zimmerman S, Martin D
Cureus. 2022; 14(7):e27052.
PMID: 36000106
PMC: 9389603.
DOI: 10.7759/cureus.27052.
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Marin S, Martin Val A, Peligero M, Rodriguez-Bernuz C, Perez-Ricart A, Vilaro Jaques L
Pharmaceuticals (Basel). 2022; 15(5).
PMID: 35631460
PMC: 9144263.
DOI: 10.3390/ph15050634.
Erythrodermic psoriasis in post-coronavirus disease 2019 patient.
Batubara I, Budianti W
Asia Pac Allergy. 2022; 12(2):e16.
PMID: 35571549
PMC: 9066080.
DOI: 10.5415/apallergy.2022.12.e16.
First-Trimester Impetigo Herpetiformis Leads to Stillbirth: A Case Report.
Liu J, Ali K, Lou H, Wang L, Wu L
Dermatol Ther (Heidelb). 2022; 12(5):1271-1279.
PMID: 35499740
PMC: 9059450.
DOI: 10.1007/s13555-022-00735-9.
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center.
Huang Y, Tsai T
Front Med (Lausanne). 2022; 8:812010.
PMID: 35004790
PMC: 8733241.
DOI: 10.3389/fmed.2021.812010.
Management of Psoriasis During the Coronavirus Disease 2019 Pandemic.
Tan K, Encarnacion M, Marushchak O, Anvekar R
J Clin Aesthet Dermatol. 2022; 14(9):41-44.
PMID: 34980970
PMC: 8675334.
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
Rosi E, Fastame M, Di Cesare A, Silvi G, Pimpinelli N, Prignano F
J Clin Med. 2021; 10(24).
PMID: 34945136
PMC: 8703332.
DOI: 10.3390/jcm10245841.
Biologics for Psoriasis During the COVID-19 Pandemic.
Zeng H, Wang S, Chen L, Shen Z
Front Med (Lausanne). 2021; 8:759568.
PMID: 34938746
PMC: 8685238.
DOI: 10.3389/fmed.2021.759568.
[Erythrodermic psoriasis after COVID-19].
Demiri J, Abdo M, Tsianakas A
Hautarzt. 2021; 73(2):156-159.
PMID: 34905074
PMC: 8670040.
DOI: 10.1007/s00105-021-04931-0.
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.
Hu S, Jiang S, Qi X, Bai R, Ye X, Xie T
Drug Dev Res. 2021; 83(1):16-54.
PMID: 34762760
PMC: 8653368.
DOI: 10.1002/ddr.21895.
On the importance of physicochemical parameters of copper and aminosilane functionalized mesoporous silica for hydroxychloroquine release.
Olejnik A, Goscianska J
Mater Sci Eng C Mater Biol Appl. 2021; 130:112438.
PMID: 34702523
PMC: 8445882.
DOI: 10.1016/j.msec.2021.112438.
Pustular psoriasis flare-up in a patient with COVID-19.
Miladi R, Janbakhsh A, Babazadeh A, Aryanian Z, Ebrahimpour S, Barary M
J Cosmet Dermatol. 2021; 20(11):3364-3368.
PMID: 34619013
PMC: 8661619.
DOI: 10.1111/jocd.14508.
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.
Diotallevi F, Campanati A, Radi G, Martina E, Rizzetto G, Barbadoro P
Dermatol Ther (Heidelb). 2021; 11(6):1889-1903.
PMID: 34586598
PMC: 8480269.
DOI: 10.1007/s13555-021-00610-z.
Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs.
Mroz M, Mucka S, Miodonska M, Ziolkowska D, Hadas E, Bozek A
Medicina (Kaunas). 2021; 57(9).
PMID: 34577804
PMC: 8470849.
DOI: 10.3390/medicina57090881.
The COVID-19 pandemic and its skin effects.
Zara A, Fleming P, Lee K, Lynde C
Can Fam Physician. 2021; 67(8):582-587.
PMID: 34385203
PMC: 9683400.
DOI: 10.46747/cfp.6708582.
New-onset guttate psoriasis secondary to COVID-19.
Rouai M, Rabhi F, Mansouri N, Jaber K, Dhaoui R
Clin Case Rep. 2021; 9(7):e04542.
PMID: 34336212
PMC: 8319378.
DOI: 10.1002/ccr3.4542.
